Literature DB >> 9469460

Primary gamma delta cell clones can be defined phenotypically and functionally as Th1/Th2 cells and illustrate the association of CD4 with Th2 differentiation.

L Wen1, D F Barber, W Pao, F S Wong, M J Owen, A Hayday.   

Abstract

The division of CD4+ alpha beta T cells into Th1 and Th2 subsets has become an established and important paradigm. The respective activities of these subsets appear to have profound effects on the course of infectious and autoimmune diseases. It is believed that specific programs of differentiation induce the commitment of an uncommitted Th0 precursor cell to Th1 or Th2. A component of these programs is hypothesized to be the nature of MHC-peptide antigen presentation to the alpha beta T cell. It has heretofore remained uncertain whether a Th1/Th2 classification likewise defines, at the clonal level, gamma delta T cells. Such cells do not, as a general rule, express either CD4 or CD8 alpha beta, and they do not commonly recognize peptide-MHC. In this report, gamma delta cell clones are described that conform strikingly to the Th1/Th2 classification, both by cytokine expression and by functional activities of the clones in vitro and in vivo. Provocatively, both the gamma delta cell clones and primary gamma delta cells in vivo showed a strong association of the Th2 phenotype with CD4 expression. These results are discussed with regard to the immunoregulatory role that is increasingly emerging for gamma delta cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9469460

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  33 in total

Review 1.  gamma delta T cells in autoimmunity.

Authors:  Z Yin; J Craft
Journal:  Springer Semin Immunopathol       Date:  2000

2.  Recognition by human gut gamma delta cells of stress inducible major histocompatibility molecules on enterocytes.

Authors:  E Griffith; E Ramsburg; A Hayday
Journal:  Gut       Date:  1998-08       Impact factor: 23.059

Review 3.  Mechanisms of immune resolution.

Authors:  Alfred Ayala; Chun-Shiang Chung; Patricia S Grutkoski; Grace Y Song
Journal:  Crit Care Med       Date:  2003-08       Impact factor: 7.598

Review 4.  Do functional subsets of leukocytes arise by divergent or linear differentiation?

Authors:  Alistair Noble; David M Kemeny
Journal:  Immunology       Date:  2002-08       Impact factor: 7.397

Review 5.  The role of gamma/delta T cells in immunity to infection and regulation of inflammation.

Authors:  H Kirk Ziegler
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

6.  Integrated immune responses to infection - cross-talk between human gammadelta T cells and dendritic cells.

Authors:  Matthias Eberl; Hassan Jomaa; Adrian C Hayday
Journal:  Immunology       Date:  2004-07       Impact factor: 7.397

7.  Characterization of avian γδ T-cell subsets after Salmonella enterica serovar Typhimurium infection of chicks.

Authors:  Jana Pieper; Ulrich Methner; Angela Berndt
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

8.  Effects of aging on human leukocytes (part II): immunophenotyping of adaptive immune B and T cell subsets.

Authors:  Ulrik Stervbo; Cecilia Bozzetti; Udo Baron; Karsten Jürchott; Sarah Meier; Julia Nora Mälzer; Mikalai Nienen; Sven Olek; Dominika Rachwalik; Axel Ronald Schulz; Avidan Neumann; Nina Babel; Andreas Grützkau; Andreas Thiel
Journal:  Age (Dordr)       Date:  2015-09-02

9.  Human immunodeficiency virus type 1 induces persistent changes in mucosal and blood gammadelta T cells despite suppressive therapy.

Authors:  Michael A Poles; Shady Barsoum; Wenjie Yu; Jian Yu; Patricia Sun; Jeanine Daly; Tian He; Saurabh Mehandru; Andrew Talal; Martin Markowitz; Arlene Hurley; David Ho; Linqi Zhang
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

10.  Induction of insulitis by glutamic acid decarboxylase peptide-specific and HLA-DQ8-restricted CD4(+) T cells from human DQ transgenic mice.

Authors:  L Wen; F S Wong; L Burkly; M Altieri; C Mamalaki; D Kioussis; R A Flavell; R S Sherwin
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.